drug safety tips

20 Jan: The dangers of anti-depressants

Fox News ran a provocative story Thursday slamming Big Pharma for overhyping the benefits — and downplaying the dangers — of anti-depressants such as Paxil, Zoloft, Prozac and Effexor. You can read the transcript here or watch the piece below. Frankly, it’s surprising to me to see this kind of anti-Big Pharma slant from Fox News. We’ll see where they go with the story.

03 Dec: Top 25 prescription medication searches for November 2007

Here are the top 25 searches on eDrugSearch.com for the month of November: Accupril Crestor Viagra Plavix Yasmin Lipitor Acyclovir Zyprexa Vytorin Diovan Strattera Climara Levitra Imitrex Simvastatin Zetia Latisse Crestor Abilify Synthroid Topamax Amoxicillin Zetia Combivent Valtrex As we state each month, the list isn’t a perfect reflection of the most popular drugs purchased online, largely because of Google. For a variety of reasons, eDrugSearch.com appears very high in the organic search results for some drugs, but not as high for others. This obviously skews our results. With this caveat, however, we hope that over time our results will shed light on trends in online drug sales. We’ll post our December results next month.

19 Nov: Defining Health 2.0: It’s All About the Consumer

Frankie Dolan has a great post about the definition of Health 2.0 and how it differs from Medicine 2.0. “I have come to think of Health 2.0 websites as being those that provide services geared towards the consumer, and Medicine 2.0 those geared towards services for the medical professional” eDrugSearch is directed at the consumer, so by Frankie’s definition we are a Health 2.0 company.  And a good thing too since I have a real passion for using technology to empower the consumer. What do you think would make a good Health 2.0 application for consumers?  What is missing out there?

05 Nov: The hypocrisy of drug re-importation laws, continued…

Sooooo… the FDA says it doesn’t inspect drugs imported from China and India (and sold through U.S. pharmacies) for safety. Did you know that almost 80 percent of the active ingredients in prescription drugs sold in the U.S. come from these countries? And yet, the FDA still wastes its time with the “issue” of U.S. consumers buying drugs from licensed Canadian pharmacies. Something doesn’t quite add up, does it? Watch the Lou Dobbs report:

24 Oct: Read our RX drug tips in NSIDE MD magazine in San Antonio, Texas

We’ve begun writing a bimonthly column for a wonderful San Antonio publication called NSIDE MD magazine. We invite you to read our first article, Five Tips for Choosing an Online Pharmacy. With the coverage we’ve received from the San Antonio Express-News, the San Antonio Business Journal and local TV, we’re feeling very “loved” by our hometown media. But we’re just getting started, folks … today San Antonio, tomorrow the world 🙂

18 Oct: Top 25 prescription drug searches

We thought it would be of interest to pharma bloggers and others to share a monthly list of the most-searched-for medication prices on eDrugSearch.com. Here are the top 25 searches for the month of September: Simvastatin prices Abilify prices Synthroid prices Yasmin prices Lipitor prices Lamisil prices Symbicort prices Levitra prices Xenical prices Vytorin prices Topamax prices Zetia prices Zoloft prices Crestor prices Cialis prices Aciphex prices Prevacid prices Lisinopril prices Viagra prices Plavix prices Celebrex prices Singulair prices Risperdal prices Diovan prices Casodex prices The list isn’t a perfect reflection of the most popular drugs purchased online, largely because of Google. For a variety of reasons, eDrugSearch.com appears very high in the organic search results for some drugs, but…

26 Sep: Better nutrition now, fewer pills later

In this 10-minute video, Natalie, a lovely Austin, Texas-based nutritionist, discusses how to improve your diet so you can take fewer statins (cholesterol drugs like Simvastatin), proton pump inhibitors (drugs for heartburn and acid reflux like Nexium and Prilosec) and antidepressants (Prozac, Zoloft, etc.)

20 Sep: Want to see a Wookiee? Take Vfend!

Lord knows there are tons of Star Wars fans out there who would give their collector lightsabers and Darth Vader helmets to have a close encounter with a Wookiee — but it turns out all you need is a fungal infection and a prescription for Pfizer’s Vfend. From CNBC: At a scientific conference in Chicago this week, a researcher presented the results of a study showing that 12% of the people who take Vfend start seeing things. Like Chewy. Yep, the scientist told doctors at the Interscience Conference on Antimicrobial Agents and Chemotherapy meeting that one patient claims to have had visions of Wookiees after taking Vfend. So here’s Les’ hilarious take on all this: “Included in the reported visions…

12 Sep: Drug safety: No more excuses

If you’re like me, you’ve had it with the FDA’s lax enforcement of Big Pharma on safety issues. It’s time to write your Congressperson about it: U.S.PIRG, the federation of state Public Interest Research Groups (PIRGs), has put together an online petition for you to sign. The petition states: Dear Chairman Edward Kennedy, Chairman John Dingell, Ranking Member Michael Enzi, Ranking Member Joe Barton: Please include in the final FDA reform bill the strongest drug safety language possible. This will protect consumers from dangerous and deadly prescription drugs such as Vioxx. The final bill should contain the House language to publicize clinical studies conducted on drugs so that doctors, researchers and patients know of potentially harmful side effects. It should…

05 Sep: Exubera: inhaler or rolling pin?

Although Exubera is turning out to be a flop, you can’t say it’s not good for something. Turns out it’s good for disciplining deadbeat husbands, fighting off dogs while jogging, and rolling dough. According to analysts, Pfizer was slow to market with Exubera, initially assigning it to a sales team that was not prepared to explain it to doctors, and then not beginning to advertise it until this summer. Some doctors complain the Exubera inhaler costs too much and isn’t covered by many insurers. It also looks like something you would find in a college frat house. Pfizer vice chairman David Shedlarz responded to this uproar by saying, “Exubera was not our finest day. We made a lot of mistakes…

30 Aug: A kidney punch to Congressional ethics

From GoozNews via The Health Care Blog: …Last week, I learned that the [children’s health insurance] bill contains another unheralded earmark, also unrelated to children’s health. This one, too, funnels hundreds of millions of dollars to special interests … given the Orwellian name “Quality Incentive Payments in the End Stage Renal Disease Program,” [it] will subject hundreds of thousands of Americans on dialysis to unnecessary risk, and will in all likelihood lead to premature deaths. The legislation earmarks up to $300 million over the next three years for clinics that achieve certain quality benchmarks while treating the more than 300,000 Americans with failed or failing kidneys who receive dialysis through Medicare’s End Stage Renal Disease (ESRD) program. Chief among those…

23 Aug: Hydrocodone supplants OxyContin as the new “hillbilly heroin”

A few years ago, OxyContin was all over the news because of Rush Limbaugh’s much-publicized addiction — and also because its illicit use was so widespread in Appalachia that it was known as “hillbilly heroin.” We’re not sure about Rush, but apparently the hillibillies have moved on — to hydrocodone. According to the AP: As OxyContin came under scrutiny, doctors were more careful about how they prescribed it. Many switched to hydrocodone products, which were already popular but didn’t have the same stigma. All 50 states saw increases in the distribution of hydrocodone between 2001 and 2005. But the trend was particularly significant in the South, where all of the top 10 states in terms of increased distribution are located,…

19 Aug: Provide a free service to your blog readers: Add a drug-search widget

As readers of our blog should know by now, we’re passionate about what we do at eDrugSearch.com. Yes, we’re a for-profit business — or at least we plan to be. (We’re currently generating zero revenues as we work to grow our member base.) But we’re also on a mission that has nothing to do with making money. We’re fed up with America’s corporate healthcare system — and specifically with Big Pharma’s greed in sucking every last dollar it can from our country’s elderly, working poor, and others who can barely afford to purchase prescription drugs. eDrugSearch.com gives these people an alternative — a place where they can feel safe in searching for lower-cost drugs from licensed pharmacies in countries like…

15 Aug: Avandia gets black-boxed

From HealthDay News: The widely used but controversial diabetes drug Avandia will now have a strong “black box” warning on its label, advising users of an increased risk of heart failure, the U.S. Food and Drug Administration announced late Tuesday. Another four diabetes drugs from the same class, including Actos, will also carry a similar black-box message, which is the agency’s strongest label warning. The FDA and the drug manufacturers, GlaxoSmithKline and Takeda Pharmaceuticals, have been negotiating the label changes since May. Studies have suggested that Avandia (rosiglitazone), made by Glaxo, and Actos (pioglitazone), made by Takeda, raise patients’ odds for heart failure. Other research has suggested that Avandia might possibly raise users’ risk for heart attack, though the FDA…